Literature DB >> 11331405

Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus.

R Martín-Ruiz1, L Ugedo, M A Honrubia, G Mengod, F Artigas.   

Abstract

We studied the control of dorsal raphe (DR) serotonergic neurons by dopaminergic transmission in rat brain using microdialysis and single unit extracellular recordings. Apomorphine (0.5-3.0 mg/kg s.c.) and quinpirole (0.5 mg/kg s.c.) increased serotonin (5-HT) output in the DR and (only apomorphine) in striatum. These effects were antagonized by 0.3 mg/kg s.c. SCH 23390 (in DR and striatum) and 1 mg/kg s.c. raclopride (in DR). 5-HT(1A) receptor blockade potentiated the 5-HT increase produced by apomorphine in the DR. Apomorphine (50-400 microg/kg i.v.) increased the firing rate of most 5-HT neurons, an effect prevented by SCH 23390 and raclopride. Quinpirole (40-160 microg/kg i.v.) also enhanced the firing rate of 5-HT neurons. When applied in the DR, neither drug increased the 5-HT output in the DR or striatum. Likewise, micropressure injection of quinpirole (0.2-8 pmol) failed to increase the firing rate of 5-HT neurons. In situ hybridization showed that the dopamine (DA) D(2) receptor transcript was almost absent in the DR and abundant in the substantia nigra (SN) and the periaqueductal grey matter (PAG). Using dual probe microdialysis, the application of tetrodotoxin or apomorphine in SN significantly increased the DR 5-HT output. Thus, the discrepancy between local and systemic effects of dopaminergic agonists and the absence of DA D(2) receptor transcript in 5-HT neurons suggest that DA D(2) receptors outside the DR control serotonergic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331405     DOI: 10.1046/j.1471-4159.2001.00275.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans.

Authors:  Barry V O'Neill; Rodney J Croft; Sumie Leung; Valérie Guille; Matthew Galloway; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 3.  Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.

Authors:  Vera Niederkofler; Tedi E Asher; Susan M Dymecki
Journal:  ACS Chem Neurosci       Date:  2015-03-18       Impact factor: 4.418

4.  In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

Authors:  A Bortolozzi; L Díaz-Mataix; M Toth; P Celada; F Artigas
Journal:  Psychopharmacology (Berl)       Date:  2007-01-30       Impact factor: 4.530

5.  Optogenetic Stimulation of Midbrain Dopamine Neurons Produces Striatal Serotonin Release.

Authors:  Merel Dagher; Katie A Perrotta; Sara A Erwin; Ayaka Hachisuka; Rahul Iyer; Sotiris C Masmanidis; Hongyan Yang; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2022-03-21       Impact factor: 5.780

6.  Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.

Authors:  Olga Chernoloz; Mostafa El Mansari; Pierre Blier
Journal:  Psychopharmacology (Berl)       Date:  2009-07-30       Impact factor: 4.530

7.  Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

Authors:  Pamela J Voulalas; Yadong Ji; Li Jiang; Jamila Asgar; Jin Y Ro; Radi Masri
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

Review 8.  Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

Authors:  Mostafa El Mansari; Bruno P Guiard; Olga Chernoloz; Ramez Ghanbari; Noam Katz; Pierre Blier
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

9.  The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.

Authors:  Renyu Zhang; Xiang Li; Yanan Shi; Yufeng Shao; Kaoxiang Sun; Aiping Wang; Fengying Sun; Wanhui Liu; Di Wang; Jingji Jin; Youxin Li
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

10.  Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels.

Authors:  Takashi Maejima; Olivia A Masseck; Melanie D Mark; Stefan Herlitze
Journal:  Front Integr Neurosci       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.